The Cooper Companies, Inc. Deferred Foreign Income Tax Expense (Benefit)
The Cooper Companies, Inc. (COO) reported Deferred Foreign Income Tax Expense (Benefit) of $141.80 million for the 12-month period ending 2025-10-31, per its 10-K filed 2025-12-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2025-12-05
- The Cooper Companies, Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was $141.80M, a 2.75% increase from fiscal 2024.
- The Cooper Companies, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was $138.00M, a 55.23% increase from fiscal 2023.
- The Cooper Companies, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was $88.90M, a 94.96% increase from fiscal 2022.
- The Cooper Companies, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was $45.60M.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-10-31 | $141.80M 10-K · filed 2025-12-05 | |
| 2024-10-31 | $138.00M 10-K · filed 2025-12-05 | |
| 2023-10-31 | $88.90M 10-K · filed 2025-12-05 | |
| 2022-10-31 | $45.60M 10-K · filed 2024-12-06 | |
| 2021-10-31 | -$2.49B 10-K · filed 2023-12-08 | |
| 2020-10-31 | -$4.90M 10-K · filed 2022-12-09 | |
| 2019-10-31 | -$6.90M 10-K · filed 2021-12-10 | |
| 2018-10-31 | -$14.20M 10-K · filed 2020-12-11 | |
| 2017-10-31 | -$4.60M 10-K · filed 2019-12-20 | |
| 2016-10-31 | -$6.10M 10-K · filed 2018-12-21 | |
| 2015-10-31 | -$5.90M 10-K · filed 2017-12-22 | |
| 2014-10-31 | -$9.80M 10-K · filed 2016-12-22 | -$9.86M 10-K · filed 2014-12-19 |
| 2013-10-31 | -$8.30M 10-K · filed 2015-12-18 | -$8.31M 10-K · filed 2013-12-20 |
| 2012-10-31 | -$2.38M 10-K · filed 2014-12-19 | |
| 2011-10-31 | -$2.29M 10-K · filed 2013-12-20 | |
| 2010-10-31 | $1.26M 10-K · filed 2012-12-20 | |
| 2009-10-31 | $1.17M 10-K · filed 2011-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |